The somatically acquired V600E mutation of the BRAF gene has been recently described as a molecular marker of hairy cell leukemia (HCL). We developed an allele-specific PCR for this mutation and studied 62 patients with HCL, 1 with HCL variant, 91 with splenic marginal zone lymphoma, 29 with Waldenström macroglobulinemia, and 57 with B-cell chronic lymphoproliferative disorders. The BRAF V600E mutation was detected in all HCL cases and in only 2 of the remaining 178 patients. These 2 subjects had B-cell chronic lymphoproliferative disorders that did not fulfill the diagnostic criteria for HCL. Despite the positive PCR finding, the mutation could not be detected by Sanger sequencing in these 2 cases, suggesting that it was associated with a small subclone. We conclude that the BRAF V600E mutation is present in all patients with HCL and that, in combination with clinical and morphologic features, represents a reliable molecular marker for this condition.
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms / L. Arcaini, S. Zibellini, E. Boveri, R. Riboni, S. Rattotti, M. Varettoni, M.L. Guerrera, M. Lucioni, A. Tenore, M. Merli, S. Rizzi, L. Morello, C. Cavalloni, M.C. Da Via, M. Paulli, M. Cazzola. - In: BLOOD. - ISSN 0006-4971. - 119:1(2012 Jan), pp. 188-191. [10.1182/blood-2011-08-368209]
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms
M.C. Da Via;
2012
Abstract
The somatically acquired V600E mutation of the BRAF gene has been recently described as a molecular marker of hairy cell leukemia (HCL). We developed an allele-specific PCR for this mutation and studied 62 patients with HCL, 1 with HCL variant, 91 with splenic marginal zone lymphoma, 29 with Waldenström macroglobulinemia, and 57 with B-cell chronic lymphoproliferative disorders. The BRAF V600E mutation was detected in all HCL cases and in only 2 of the remaining 178 patients. These 2 subjects had B-cell chronic lymphoproliferative disorders that did not fulfill the diagnostic criteria for HCL. Despite the positive PCR finding, the mutation could not be detected by Sanger sequencing in these 2 cases, suggesting that it was associated with a small subclone. We conclude that the BRAF V600E mutation is present in all patients with HCL and that, in combination with clinical and morphologic features, represents a reliable molecular marker for this condition.File | Dimensione | Formato | |
---|---|---|---|
zh800112000188.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
220.33 kB
Formato
Adobe PDF
|
220.33 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.